Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

12345678910...
CompanyDrug NameStatusIndication Group
Genentech Xolair Approved in USARespiratory system
Novartis Xolair Approved in EU, submitted for approval in JapanRespiratory system
Tanox Xolair Approved in EUAntineoplastic & immunomodulating agents
Novartis Xolair in Phase IIIRespiratory system
Novartis Xolair in Phase IIIRespiratory system
Genentech Xolair Approved in USARespiratory system
Cell Therapeutics Xiotax accomplished Phase IIIAntineoplastic & immunomodulating agents
Cell Therapeutics Xiotax in Phase IIIAntineoplastic & immunomodulating agents
Abbott Laboratories Xinlay Approved in EUAntineoplastic & immunomodulating agents
Abbott Laboratories Xinlay discontinuedAntineoplastic & immunomodulating agents
Ista Xibrom Approved in USASensory organs
Neurobiological Technologies Xerecept in Phase IIINervous system
Roche XENICAL Approved in EU, submitted for approval in USAAlimentary tract & metabolism
Roche XENICAL in Phase IIAlimentary tract & metabolism
Roche XELODA in Phase IIIAntineoplastic & immunomodulating agents
Roche XELODA Approved in USA and EUAntineoplastic & immunomodulating agents
Pharmacyclics xcytrin injection in Phase IIAntineoplastic & immunomodulating agents
Pharmacyclics Xcytrin Submitted for approval in USAAntineoplastic & immunomodulating agents
Pharmacyclics Xcytrin in Phase IIAntineoplastic & immunomodulating agents
Pharmacyclics Xcytrin accomplished Phase IAntineoplastic & immunomodulating agents
12345678910...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.